 Ocular Therapeutix NASDAQ: OCUL announces its next round of earnings this Friday, August 07. Here is Benzingas look at Ocular Therapeutixs Q2 earnings report.Earnings and Revenue Sell-side analysts are expecting Ocular Therapeutixs loss per share to be near 0.31. In the same quarter last year, Ocular Therapeutix posted EPS of -0.57. If the company were to post earnings in-line with the consensus estimate when it reports Friday, EPS would be up 45.61. Heres how the companys reported EPS has stacked up against analyst estimates in the past:Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019 EPS Estimate -0.37 -0.45 -0.47 -0.48 EPS Actual -0.41 -0.53 -0.45 -0.57 Revenue Estimate 2.84 M 2.54 M 580.00 K 740.00 K Revenue Actual 2.61 M 2.26 M 829.00 K 650.00 K Stock Performance Over the last 52-week period, shares are up 93.1. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release.View more earnings on OCULDont be surprised to see the stock move on comments made during its conference call. Ocular Therapeutix is scheduled to hold the call at 08:30:00 ET and can be accessed here: more from Benzinga Stocks That Hit 52-Week Highs On Wednesday Stocks That Hit 52-Week Highs On ThursdayC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 